Metabolic syndrome, subclinical coronary atherosclerosis, and cardiovascular risk.

Catherine Y. Campbell, Khurram Nasir, Roger S. Blumenthal

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


The metabolic syndrome is a constellation of cardiovascular disease risk factors, and it is associated with the presence of advanced subclinical coronary atherosclerosis. The presence of the metabolic syndrome appears to provide incremental predictive value on top of the Framingham risk score in predicting future cardiovascular events. Traditional risk-prediction formulas fail to account for a significant portion of coronary heart disease morbidity and mortality. The metabolic syndrome may be particularly useful in predicting risk among individuals classified as low or intermediate risk by Framingham risk score.

Original languageEnglish (US)
Pages (from-to)105-110
Number of pages6
JournalThe American heart hospital journal
Issue number2
StatePublished - Jan 1 2005

ASJC Scopus subject areas

  • Leadership and Management
  • Health Policy
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Metabolic syndrome, subclinical coronary atherosclerosis, and cardiovascular risk.'. Together they form a unique fingerprint.

Cite this